{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T16:08:57Z","timestamp":1710346137296},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"DOI":"10.7759\/cureus.54572","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:31:00Z","timestamp":1708475460000},"source":"Crossref","is-referenced-by-count":0,"title":["Eye Plaque Brachytherapy for Choroidal Malignant Melanoma: A Case Report on the Use of Innovative Technology to Expand Access, Improve Practice, and Enhance Outcomes"],"prefix":"10.7759","author":[{"given":"Paul","family":"Mobit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Chunli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary R","family":"Nittala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba Z","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Shultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasan","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18","volume":"119","author":"Diener-West M","year":"2001","unstructured":"Diener-West M, Earle JD, Fine SL, et al.. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol. 2001, 119:969-82. 10.1001\/archopht.119.7.969","journal-title":"Arch Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28","volume":"124","year":"2006","unstructured":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006, 124:1684-93. 10.1001\/archopht.124.12.1684","journal-title":"Arch Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1017\/S1460396909990197","article-title":"Comparing plaque brachytherapy and proton therapy for choroidal melanoma: A review of the literature","volume":"9","author":"Appleton JP","year":"2010","unstructured":"Appleton JP, Bridge P. Comparing plaque brachytherapy and proton therapy for choroidal melanoma: A review of the literature. JRP. 2010, 9:53-61. 10.1017\/S1460396909990197","journal-title":"JRP"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2017.07.014","article-title":"Patterns of care and outcomes of proton and eye plaque brachytherapy for uveal melanoma: review of the National Cancer Database","volume":"16","author":"Lin AJ","year":"2017","unstructured":"Lin AJ, Rao YJ, Acharya S, Schwarz J, Rao PK, Grigsby P. Patterns of care and outcomes of proton and eye plaque brachytherapy for uveal melanoma: review of the National Cancer Database. Brachytherapy. 2017, 16:1225-31. 10.1016\/j.brachy.2017.07.014","journal-title":"Brachytherapy"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.07.017","article-title":"A systematic comparison of dose distributions delivered in 125I plaque brachytherapy and proton radiation therapy for ocular melanoma","volume":"115","author":"Trofimov AV","year":"2023","unstructured":"Trofimov AV, Aronow ME, Gragoudas ES, Keane FK, Kim IK, Shih HA, Bhagwat MS. A systematic comparison of dose distributions delivered in 125I plaque brachytherapy and proton radiation therapy for ocular melanoma. Int J Radiat Oncol Biol Phys. 2023, 115:501-10. 10.1016\/j.ijrobp.2022.07.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mp.13996","article-title":"AAPM recommendations on medical physics practices for ocular plaque brachytherapy: report of task group 221","volume":"47","author":"Thomson RM","year":"2020","unstructured":"Thomson RM, Furutani KM, Kaulich TW, et al.. AAPM recommendations on medical physics practices for ocular plaque brachytherapy: report of task group 221. Med Phys. 2020, 47:e92-124. 10.1002\/mp.13996","journal-title":"Med Phys"},{"key":"ref7","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Melanoma. Uveal. (2022). Accessed: February 12, 2023: https:\/\/www.nccn.org\/guidelines\/guidelines-detail."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09553008514550461","article-title":"An \"incomplete-repair\" model for survival after fractionated and continuous irradiations","volume":"47","author":"Thames HD","year":"1985","unstructured":"Thames HD. An \"incomplete-repair\" model for survival after fractionated and continuous irradiations. Int J Radiat Biol Relat Stud Phys Chem Med. 1985, 47:319-39. 10.1080\/09553008514550461","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao ST","year":"2012","unstructured":"Chiu-Tsao ST, Astrahan MA, Finger PT, et al.. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Med Phys. 2012, 39:6161-84. 10.1118\/1.4749933","journal-title":"Med Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/161788-eye-plaque-brachytherapy-for-choroidal-malignant-melanoma-a-case-report-on-the-use-of-innovative-technology-to-expand-access-improve-practice-and-enhance-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:31:05Z","timestamp":1708475465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/161788-eye-plaque-brachytherapy-for-choroidal-malignant-melanoma-a-case-report-on-the-use-of-innovative-technology-to-expand-access-improve-practice-and-enhance-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.54572","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}